Smartening Africa’s Drug Supply Chain with IBM AI

By Crystal Lubbe

November 27, 2024

The article from Bizcommunity titled “African Drug Supply Chain Gets Smarter with IBM-Powered AI Platform” highlights a major initiative aimed at enhancing the pharmaceutical supply chain in Africa through the use of advanced technologies, focusing on AI and digital solutions. This initiative revolves around the establishment of the Pulse platform by NABP, designed to improve efficiency and transparency within the African drug supply chain.

Collaboration and Partnerships

This initiative involves a collaboration between Prosper Africa, USAID’s e-Trade Alliance, IBM Consulting, and the National Association of Boards of Pharmacy (NABP) to launch a platform called Pulse by NABP in South Africa. This partnership aims to connect US and global pharmaceutical companies like Pfizer and Roche with African distributors and pharmacies, proving critical in strengthening the African drug supply chain.

Use of AI and Digital Solutions

The Pulse platform leverages IBM’s Watson AI capabilities to enhance the traceability of drugs exported to Africa. This initiative not only improves supply chain visibility but also reduces spoilage, ensuring consistent stock levels. Furthermore, it fosters profitable partnerships with international suppliers. IBM Consulting will utilize its AI-powered delivery platform, IBM Consulting Advantage, to collect and analyse product scan data, enabling pharmacies and retailers to make more informed, data-driven decisions. Ultimately, this enhances the African drug supply chain.

Market Opportunities and Challenges

The African pharmaceutical market, valued at $26.85 billion in 2023, is projected to grow 3.4% annually from 2024 to 2030. However, fragmented supply chains, poor infrastructure, and diverse regulations hinder efficient pharmaceutical distribution across African countries. These challenges result in supply inefficiencies, limited product availability, and higher patient costs, complicating efforts to improve the drug supply chain.

Benefits of the Platform

Enhanced Traceability: The platform improves the ability to identify and trace medications, ensuring greater security in the drug supply chain.
Inventory Optimization: AI tools help minimise stockouts and overstock situations by optimising inventory levels.
Improved Operations: The platform enhances operations for African distributors and pharmacies, leading to more efficient and profitable supply chains.
Economic and Social Impact: This initiative enhances economic growth and health by improving supply chain visibility and creating a transparent, accessible medication market.

Training and Capacity Building

IBM will offer training on AI tools like Watsonx.ai to help African pharmacies and retailers utilise data-driven decision-making effectively. This training is part of a broader strategy to build resilient ecosystems that drive economic growth and societal impact.

Public-Private Collaboration

Altogether, collaboration between public and private entities undoubtedly reflects the potential to drive both economic growth and health improvements. Furthermore, emphasises the use of technology and expertise to enhance transparency and foster trust in vital industries like healthcare.

The Pulse by NABP, powered by IBM AI, addresses Africa’s pharmaceutical supply chain challenges through traceability and operational efficiency.
This initiative benefits US companies and African consumers by improving medication access and strengthening the African drug supply chain.

Reference url

Recent Posts

lenacapavir HIV PrEP access
    

Global Health Partnerships Unite to Expand Access to Lenacapavir for HIV Prevention

💉 How can we ensure equitable access to HIV prevention methods like lenacapavir?

A recent initiative from the Global Fund, supported by key global health organizations, aims to provide affordable access to this new HIV pre-exposure prophylaxis medication.

With a goal to reach 2 million individuals over three years, this coordinated effort seeks to drastically cut HIV infections and align with our commitment to ending AIDS by 2030.

Explore the details of this impactful collaboration and how it could transform HIV prevention.

#SyenzaNews #globalhealth #HealthcareInnovation #MarketAccess

antimicrobial resistance africa
     

Africa’s Health Crisis: Antimicrobial Resistance and Mpox Outbreak

🌍 Are we prepared to tackle the hidden pandemic of antimicrobial resistance (AMR) in Africa?

With AMR rapidly becoming a dominant health crisis, it’s critical to understand its impact on our healthcare systems and most vulnerable populations.

The Africa CDC highlights the urgent need for substantial investment and coordinated responses to combat this escalating threat, alongside the ongoing Mpox outbreak.

Discover the pressing challenges and potential solutions in our latest article.

#SyenzaNews #GlobalHealth #HealthcareInnovation #AntimicrobialResistance #PublicHealth

BioSapien cancer drug delivery
    

BioSapien Innovative Cancer Drug Delivery Solutions

🌟 How is innovation in drug delivery shaping the future of cancer treatment? 🌟

Discover how UAE-based BioSapien is transforming the healthcare landscape with the MediChip™ platform, securing $5.5 million in pre-Series A funding to enhance cancer care.

This innovative solution promises to minimise side effects and improve treatment outcomes for patients, fully embracing the potential of biotechnology in the fight against cancer.

Read more about BioSapien’s journey and its impact on global health!

#SyenzaNews #biotechnology #oncology #innovation #HealthTech

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.